Tandem Diabetes Care, Inc.
MX ˙ BMV ˙ US8753722037
SecurityMX:TNDM / Tandem Diabetes Care, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership294,052 shares
Latest Disclosed Value $ 5,636,977
Invesco Ltd. reports 5.88% increase in ownership of TNDM / Tandem Diabetes Care, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 294,052 shares of Tandem Diabetes Care, Inc. (MX:TNDM) valued at $5,636,977 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 277,722 shares of Tandem Diabetes Care, Inc.. This represents a change in shares of 5.88% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 294,052 16,330 5.88 5,637 -7.67 0.0009
2026-02-19 2025-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 277,722 -24,319 -8.05 6,104 66.50 0.0009
2025-11-13 2025-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 302,041 75,252 33.18 3,667 -13.27 0.0006
2025-08-13 2025-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 226,789 -10,333 -4.36 4,227 -6.96 0.0007
2025-05-12 2025-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 237,122 32,232 15.73 4,543 -38.44 0.0009
2025-02-13 2024-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 204,890 -112,695 -35.48 7,380 -45.20 0.0014
2024-11-12 2024-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 317,585 114,084 56.06 13,469 64.26 0.0026
2024-08-13 2024-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 203,501 -49,431 -19.54 8,199 -8.45 0.0017
2024-05-14 2024-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 252,932 7,245 2.95 8,956 23.24 0.0019
2024-02-13 2023-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 245,687 -28,147 -10.28 7,267 27.78 0.0017
2023-11-13 2023-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 273,834 -22,508 -7.60 5,688 -21.80 0.0015
2023-08-11 2023-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 296,342 -1,598 -0.54 7,272 -39.90 0.0019
2023-05-12 2023-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 297,940 197,590 196.90 12,099 168.27 0.0034
2023-02-13 2022-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 100,350 -1,131,636 -91.85 4,511 -92.35 0.0013
2022-11-14 2022-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 1,231,986 -933,825 -43.12 58,950 -54.02 0.0190
2022-08-15 2022-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 2,165,811 85,638 4.12 128,194 -47.01 0.0388
2022-05-16 2022-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 2,080,173 137,202 7.06 241,904 -17.29 0.0617
2022-02-14 2021-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 1,942,971 205,453 11.82 292,456 40.99 0.0705
2021-11-15 2021-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 1,737,518 134,364 8.38 207,425 32.84 0.0526
2021-08-17 2021-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 1,603,154 -167,697 -9.47 156,147 -0.08 0.0384
2021-05-17 2021-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 1,770,851 18,172 1.04 156,277 -6.81 0.0417
2021-02-16 2020-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 1,752,679 141,373 8.77 167,696 -8.30 0.0488
2020-11-16 2020-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 1,611,306 7,481 0.47 182,882 15.27 0.0618
2020-08-14 2020-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 1,603,825 -59,867 -3.60 158,650 48.19 0.0567
2020-05-15 2020-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 1,663,692 873,780 110.62 107,059 127.36 0.0451
2020-02-14 2019-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 789,912 466,839 144.50 47,087 147.11 0.0146
2019-11-14 2019-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 323,073 224,277 227.01 19,055 198.95 0.0050
2019-08-14 2019-06-30 13F/A-1 TANDEM DIABETES CARE COM NEW 875372203 98,796 -41,908 -29.78 6,374 -28.66 0.0016
2019-08-14 2019-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 98,796 -119,624 6,374
2019-05-15 2019-03-31 13F TANDEM DIABETES CARE COM NEW 875372203 140,704 59,134 72.49 8,935 188.51 0.0030
2019-02-14 2018-12-31 13F TANDEM DIABETES CARE COM NEW 875372203 81,570 45,582 126.66 3,097 100.84 0.0012
2018-11-14 2018-09-30 13F TANDEM DIABETES CARE COM NEW 875372203 35,988 616 1.74 1,542 97.95 0.0005
2018-08-14 2018-06-30 13F TANDEM DIABETES CARE COM NEW 875372203 35,372 35,372 779 0.0003
2015-11-16 2015-09-30 13F TANDEM DIABETES CARE-REDH COMMON 875372104 0 -4,017 -100.00 0 -100.00
2015-08-14 2015-06-30 13F TANDEM DIABETES CARE-REDH COMMON 875372104 4,017 4,017 44 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.